Efficacy and safety of etanercept in the treatment of recalcitrant psoriasis: An open-label, retrospective, observational study in Taiwan
Background: Psoriasis is a chronic inflammatory disease affecting the quality of life of patients. Traditional treatments are limited by adverse side effects. Etanercept is a biological agent used as an alternative treatment for psoriasis. Methods: This open-label, observational study conducted in T...
Saved in:
Main Authors: | Yi-Fang Wu (Author), Yi-Chin Shin (Author), Chih-Hsun Yang (Author), Yu-Huei Huang (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2013-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of etanercept biosimilar rhTNFR-Fc in Chinese patients with juvenile idiopathic arthritis: An open-label multicenter observational study
by: Xuefeng Xu, et al.
Published: (2022) -
Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan
by: Pei-Han Kao, et al.
Published: (2015) -
Etanercept in the treatment of plaque psoriasis
by: Thao U Nguyen, et al.
Published: (2009) -
Psoriasis, lymphoma and etanercept: is there a correlation? Psoríase, linfoma e etanercepte: existe correlação?
by: Ludmilla Queirós Miranda, et al.
Published: (2012) -
Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
by: Ting-Shun Wang, et al.
Published: (2013)